Levelling the Playing Field: the FDA's Regulation of Nicotine Dependence Products

DSpace/Manakin Repository

Levelling the Playing Field: the FDA's Regulation of Nicotine Dependence Products

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Szubin, Adam J. en_US
dc.date.accessioned 2012-06-07T03:22:33Z
dc.date.issued 1999 en_US
dc.identifier.citation Levelling the Playing Field: the FDA's Regulation of Nicotine Dependence Products (1999 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846773
dc.description.abstract There is a great need for the increased development and use of nicotine dependence products (NDPs) in this country. A creative regulatory approach, such as the FDA brought to tobacco regulation, could do an enormous amount of good. In the field of NDPs, as in every area of drug regulation, a new regulatory approach will bring with it costs and benefits. As our knowledge advances, the FDA should not be slow to adopt the same aggressive yet flexible approach to NDPs that it has adopted towards tobacco. It should be a short-term goal for the FDA to ensure that “each decision to smoke should present an equal opportunity not to smoke and an equal opportunity to get help.†en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject tobacco en
dc.subject nicotine en
dc.subject FDA en
dc.subject regulation en
dc.subject nicotine dependence products en
dc.title Levelling the Playing Field: the FDA's Regulation of Nicotine Dependence Products en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-06-07T03:22:33Z

Files in this item

Files Size Format View
Szubin.pdf 131.8Kb PDF View/Open
Szubin.rtf 53.28Kb RTF file View/Open
Szubin.html 51.04Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters